Figure 3
Figure 3. Phenotypic analysis of donor CMV ORF-specific memory T-cell responses in relation to CMV reactivations and magnitude of the corresponding responses in the recipient after HSCT. (A) For donor ORF-specific T-cell populations that were less differentiated (CD27+CD45RO+CD57−), there was a greater probability of persistence and expansion (increased fold change) in the recipient after HSCT. For donor ORF-specific T-cell populations that were more differentiated (CD27− memory; CD27−CD57+ memory), there was a greater probability of contraction (decreased fold change) in the recipient after HSCT. (B) In donors with a higher frequency of CD8+ CMV-specific CD27+ memory T-cell responses, fewer CMV reactivations were observed in the recipient after HSCT. Conversely, in donors with a higher frequency of more differentiated CD8+ CMV-specific memory T-cell responses (CD27−), a greater number of CMV reactivations were observed in the recipient after HSCT. No correlations between the phenotype of donor CMV-specific CD4+ T cells and the incidence of CMV reactivation in the recipient after HSCT were observed. The patients who reactivated CMV are shown in Table 1.

Phenotypic analysis of donor CMV ORF-specific memory T-cell responses in relation to CMV reactivations and magnitude of the corresponding responses in the recipient after HSCT. (A) For donor ORF-specific T-cell populations that were less differentiated (CD27+CD45RO+CD57), there was a greater probability of persistence and expansion (increased fold change) in the recipient after HSCT. For donor ORF-specific T-cell populations that were more differentiated (CD27 memory; CD27CD57+ memory), there was a greater probability of contraction (decreased fold change) in the recipient after HSCT. (B) In donors with a higher frequency of CD8+ CMV-specific CD27+ memory T-cell responses, fewer CMV reactivations were observed in the recipient after HSCT. Conversely, in donors with a higher frequency of more differentiated CD8+ CMV-specific memory T-cell responses (CD27), a greater number of CMV reactivations were observed in the recipient after HSCT. No correlations between the phenotype of donor CMV-specific CD4+ T cells and the incidence of CMV reactivation in the recipient after HSCT were observed. The patients who reactivated CMV are shown in Table 1.

Close Modal

or Create an Account

Close Modal
Close Modal